Papers - YAMAMOTO Hayato
-
Multicenter, international, retrospective study of prognostic factors for Ra223.
Oishi T, Luo HL, Hatayama Y, Kawaguchi H, Sasaki D, Tanaka R, Ishii N, Mikami J, Okamoto T, Yamamoto H, Aoki M, Su YL, Chen YH, Chang YH, Chen YT, Wang HJ, Ohyama C, Hatakeyama S.
Science report 2025.3
-
Pre-transplant tacrolimus fluctuations predict BK virus infection risk in kidney transplants
Sakurai H, Okamoto T, Yonemaya A, Yonemaya F, Hamaya T, Kodama H, Fujita N, Yamamoto Hayato, Mori K, Fujita T, Imai A, Murakami R, Tomita H, Hatakeyama S, Ohyama C.
Clinical and Experimental Nephrology 2025.3
-
Impact of Skin Adverse Events on Prognosis in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Treated With Enfortumab Vedotin: A Real-World Multicenter Study
Ozaki K, Yamamoto Hayato, Sekine Y, Horiguchi H, Hosogoe S, Mikami J, Fujita N, Tokui N, Okita K, Okamoto T, Mori K, Kobayashi M, Numakura K, Yoneyama T, Tabata R, Sato S, Habuchi T, Ohyama C, Hatakeyama S.
Multicenter Study 2025.3
-
Association between sex hormones and erectile dysfunction in men without hypoandrogenism
Fujita N, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Mikami T, Itoh K, Ohyama C, Hatakeyama S.
Sci Rep . 2024.6
-
Can Erectile Dysfunction Severity Predict Major Adverse Cardiovascular Events in Men Undergoing Dialysis? A Prospective Cohort Study
Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C.
World J Mens Health. 2023.10
-
Humoral response to SARS-CoV-2 mRNA vaccine on in ABO blood type incompatible kidney transplant recipients treated with low-dose rituximab
Tomoko Hamaya 1, Shingo Hatakeyama 2, Tohru Yoneyama 3, Yuki Tobisawa 1, Hirotake Kodama 1, Takeshi Fujita 4, Reiichi Murakami 4, Kazuyuki Mori 1, Teppei Okamoto 1, Hayato Yamamoto 1, Takahiro Yoneyama 5, Yasuhiro Hashimoto 1, Hisao Saitoh 6, Shunji Narumi 7, Hirofumi Tomita 4, Chikara Ohyama
Science report 2023.9
-
Impact of nephroureterectomy on postoperative renal function in upper tract urothelial carcinoma: A multicenter retrospective study
Yoshiharu Okuyama 1, Shingo Hatakeyama 2, Ryuji Tabata 3, Daiji Fujimori 3, Yohei Kawashima 3, Toshikazu Tanaka 4, Naoki Fujita 1, Teppei Okamoto 1, Kazuyuki Mori 1, Hayato Yamamoto 1, Takahiro Yoneyama 5, Yasuhiro Hashimoto 1, Toshimitsu Matsuoka 6, Satoshi Sato 3, Chikara Ohyama 1
Int J urology 2023.8
-
Trends in the age of hospitalized patients with urological cancers: A 17-year experience
Noritaka Ishii 1, Shingo Hatakeyama 2, Hikari Miura 1, Ryuma Tanaka 1, Takuya Oishi 1, Hirotaka Horiguchi 1, Shogo Hosogoe 1, Naoki Fujita 1, Hiromichi Iwamura 1, Teppei Okamoto 1, Hayato Yamamoto 1, Takahiro Yoneyama 3, Yasuhiro Hashimoto 1, Chikara Ohyama
int. J urology 2023.7
-
Comparison of neoadjuvant chemohormonal therapy vs. extended pelvic lymph-node dissection in high-risk prostate cancer treated with robot-assisted radical prostatectomy
Takuya Oishi 1, Shingo Hatakeyama 2, Ryuji Tabata 3, Daiji Fujimori 3, Mamoru Fukuda 3, Tetsuo Shinozaki 3, Noritaka Ishii 1, Hiromichi Iwamura 1, Teppei Okamoto 1, Hayato Yamamoto 1, Takahiro Yoneyama 4, Yasuhiro Hashimoto 1, Satoshi Sato 3, Chikara Ohyama
Sci Rep. 2023.5
-
Oncological and functional outcomes of female reproductive organ-sparing radical cystectomy and ileal neobladder construction
Hikari Miura 1, Shingo Hatakeyama 2, Toshikazu Tanaka 3, Naoki Fujita 1, Hirotaka Horiguchi 1, Ryuma Tanaka 1, Daisuke Noro 4, Noriko Tokui 5, Teppei Okamoto 1, Hayato Yamamoto 1, Takahiro Yoneyama 6, Yasuhiro Hashimoto 1, Chikara Ohyama
Urol Oncorogy 2023.5
-
Relationship between lower urinary tract symptoms and frailty
Yusuke Ozaki , Shingo Hatakeyama , Atsushi Imai , Jung Songee , Osamu Soma , Kai Ozaki , Naoki Fujita , Teppei Okamoto , Hiromichi Iwamura , Hayato Yamamoto , Takahiro Yoneyama , Yasuhiro Hashimoto , Chikara Ohyama
int. J urology 2023.4
-
Association between Aortic Calcification Burden and the Severity of Erectile Dysfunction in Men Undergoing Dialysis: A Cross-Sectional Study
Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C.
World J Mens Health. 2023.4
-
Effects of apalutamide dose reduction on skin-related adverse events in patients with advanced prostate cancer: A multicenter retrospective study
Oishi T, Hatakeyama S, Tabata R, Fujimori D, Kawashima Y, Tanaka R, Ishii N, Miura H, Tanaka T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Sato S, Ohyama C.
Multicenter Study 2023.2
-
Trends of incidence and age in adults with testicular germ cell tumors: a two-decade multicenter retrospective study
Ozaki Y, Narita T, Hatakeyama S, Tanaka T, Togashi K, Hamaya T, Ozaki K, Ishi N, Oishi T, Tokui N, Mikami J, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C.
Transl Androl Urol . 2023.2
-
Can Erectile Dysfunction Severity Predict Major Adverse Cardiovascular Events in Men Undergoing Dialysis? A Prospective Cohort Study
Fujita N, Momota M, Ozaki Y, Tobisawa Y, Yoneyama T, Okamoto T, Yamamoto H, Hatakeyama S, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C.
World J Mens Health 2023.1
-
Comparison of efficacy and medical costs between upfront docetaxel and abiraterone treatments of metastatic hormone-sensitive prostate cancer patients in real-world practice: a multicenter retrospective study
Ozaki K, Hatakeyama S, Narita S, Hata K, Yanagisawa T, Tanaka T, Togashi K, Hamaya T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Kimura T, Habuchi T, Ohyama C.
World J Urol. 2023.1
-
Oncological and functional outcomes of female reproductive organ-sparing radical cystectomy and ileal neobladder construction
Miura H, Hatakeyama S, Tanaka T, Fujita N, Horiguchi H, Tanaka R, Noro D, Tokui N, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C.
Urol Oncol 2022.12
-
Relationships of low-grade systemic inflammation and nutritional status with erectile dysfunction severity in men on dialysis
Fujita N, Hatakeyama S, Momota M, Hamaya T, Tobisawa Y, Yoneyama T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C.
Andrology 2022.11
-
Prognostic impact of proton pump inhibitors for immunotherapy in advanced urothelial carcinoma
2022.10
-
Risk score-based substratification improves surveillance costs after transurethral resection of bladder tumor in patients with primary high-risk non-muscle-invasive bladder cancer
Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama T, Yamamoto H, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C.
Sci Rep . 2022.8